WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Theravance Biopharma earnings were $53.8M for the trailing 12 months ending Jun 30, 2026, with 328% growth year over year. The latest TBPH earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$5.9M, up 19.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TBPH reported annual earnings of $105.9M, with -287.7% growth. The next TBPH earnings date is Nov 9, 2026.

TBPH past earnings growth

How has TBPH's earnings growth performed historically?

Company
328%
Industry
18.1%
Market
92.82%
TBPH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TBPH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TBPH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TBPH earnings history

Current Revenue
$104.3M
Current Earnings
$53.8M
Current Profit Margin
51.6%

TBPH Return on Equity

Current Company
19.4%
Current Industry
-13.6%
Current Market
30.9%
TBPH's Return on Equity (19.4%)... subscribe to Premium to read more.
High Return on Equity Performance

TBPH Return on Assets

Current Company
11.7%
Current Industry
-10.2%
TBPH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TBPH announces earnings.

TBPH Return on Capital Employed

Current Company
13.68%
Current Industry
-6.7%
TBPH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TBPH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TBPH$65.87M$53.81M-96.85%$1.07
FTH-$193.89M-$195.53MN/A-$141.65
WVE-$193.31M-$202.47MN/A-$1.08
AVTX-$100.05M-$100.33MN/A-$4.37
SANA-$193.29M-$211.82MN/A-$0.76
View Top Biotech Stocks

TBPH earnings dates

Next earnings date
Nov 9, 2026

Theravance Biopharma Earnings Reports & History FAQ

What were Theravance Biopharma's earnings last quarter?

On TBPH's earnings call on Aug 11, 2026, Theravance Biopharma (NASDAQ: TBPH) reported Q2 2026 earnings per share (EPS) of -$0.11, up 110.09% year over year. Total TBPH earnings for the quarter were -$5.90 million. In the same quarter last year, Theravance Biopharma's earnings per share (EPS) was $1.09.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.

When does Theravance Biopharma report earnings?

The next TBPH earnings call is Nov 9, 2026. Add TBPH to your watchlist to be reminded of Theravance Biopharma's next earnings date.

Is Theravance Biopharma profitable or losing money?

As of the last Theravance Biopharma earnings report, Theravance Biopharma is currently profitable. Theravance Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $53.81 million, a 312.92% increase year over year.

What was TBPH's earnings growth in the past year?

As of Theravance Biopharma's earnings date in Aug 11, 2026, Theravance Biopharma's earnings has grown 328% year over year. This is 309.9 percentage points higher than the US Biotechnology industry earnings growth rate of 18.1%. TBPH earnings in the past year totalled $53.81 million.

What are Theravance Biopharma's earnings expectations?

The current EPS estimate for Theravance Biopharma's earnings report in Nov 9, 2026 is $0.19.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.